Evidence map›Paper›PMID 34916595›Full record

ArticleNature chemistry2022

Engineering an efficient and enantioselective enzyme for the Morita-Baylis-Hillman reaction.

Rebecca Crawshaw, Amy E Crossley, Linus Johannissen, Ashleigh J Burke, Sam Hay, Colin Levy, David Baker, Sarah L Lovelock, Anthony P Green

Open access · greenAbstract read
In one paragraph

Article in Nature chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Promiscuity-Guided Enzyme Evolution via Substrate Multiplexed Screening.Angewandte Chemie (International ed. in English) · 2026
    Review
  4. Building Molecules by a Self-Replicator That Catalyzes Acyl Hydrazone Formation.Angewandte Chemie (International ed. in English) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. bioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Article
  16. Reinvestigation of theJournal of the American Chemical Society · 2025
    Article
  17. Designing Enzymatic Reactivity with an Expanded Palette.Chembiochem : a European journal of chemical biology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rebecca CrawshawManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
Amy E CrossleyManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
Linus JohannissenManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
Ashleigh J BurkeManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
Sam HayManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.ORCID http://orcid.org/0000-0003-3274-0938
Colin LevyManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7896-6217
Sarah L LovelockManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK. sarah.lovelock@manchester.ac.uk.ORCID http://orcid.org/0000-0002-4584-3189
Anthony P GreenManchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK. anthony.green@manchester.ac.uk.ORCID http://orcid.org/0000-0003-0454-1798
University of Manchester · GBHoward Hughes Medical Institute · US

Funding

Biotechnology and Biological Sciences Research Council BB/M017702/1Biotechnology and Biological Sciences Research Council BB/M027023/1Biotechnology and Biological Sciences Research Council BB/S507040/1European Research Council 757991Medical Research Council MR/T041722/1
6 · The paper itself

Abstract

The combination of computational design and directed evolution could offer a general strategy to create enzymes with new functions. So far, this approach has delivered enzymes for a handful of model reactions. Here we show that new catalytic mechanisms can be engineered into proteins to accelerate more challenging chemical transformations. Evolutionary optimization of a primitive design afforded an efficient and enantioselective enzyme (BH32.14) for the Morita-Baylis-Hillman (MBH) reaction. BH32.14 is suitable for preparative-scale transformations, accepts a broad range of aldehyde and enone coupling partners and is able to promote selective monofunctionalizations of dialdehydes. Crystallographic, biochemical and computational studies reveal that BH32.14 operates via a sophisticated catalytic mechanism comprising a His23 nucleophile paired with a judiciously positioned Arg124. This catalytic arginine shuttles between conformational states to stabilize multiple oxyanion intermediates and serves as a genetically encoded surrogate of privileged bidentate hydrogen-bonding catalysts (for example, thioureas). This study demonstrates that elaborate catalytic devices can be built from scratch to promote demanding multi-step processes not observed in nature.

Indexed as

ProteinsCatalysisHydrogen BondingMolecular ConformationStereoisomerismProteins

Identifiers

PMID34916595
PMCPMC7612480
OpenAlexW4200303415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.